Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Tonsillar Neoplasms × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 38 Breast Neoplasms 26 Prostatic Neoplasms 23 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Lung Neoplasms 11 Neoplasms 10 Urinary Bladder Neoplasms 8 Triple Negative Breast Neoplasms 8 Neoplasm Metastasis 7 Head and Neck Neoplasms 7 Carcinoma, Squamous Cell 6 Non-Muscle Invasive Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Transitional Cell 5 Adenocarcinoma 5 Oropharyngeal Neoplasms 4 Sarcoma 3 Recurrence 3 Prostatic Neoplasms, Castration-Resistant 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 HER2-positive Breast Cancer 3 Endometrial Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaccinia 2 Peritoneal Neoplasms 2 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer 2 Melanoma 2

Interventions

Standard of Care 1 Radiotherapy 1 Radiation 1 Practice Guidelines as Topic 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04277858 2023-10-23

NECTORS

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Recruiting

Oropharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡